BioPower Operations Corporation
BOPO
$0.0001
$0.000.00%
| 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 125.00K | 246.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 125.00K | 246.70K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 0.00 | 125.00K | 246.70K |
| SG&A Expenses | 4.45M | 50.90K | 396.20K | 403.50K | 212.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.70M | 483.20K | 396.20K | 403.50K | 212.40K |
| Operating Income | -4.70M | -483.20K | -396.20K | -278.50K | 34.30K |
| Income Before Tax | -4.76M | -629.60K | -536.90K | -243.70K | -13.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.76M | -629.60K | -536.90K | -243.70K | -13.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.76M | -629.60K | -536.90K | -243.70K | -13.10K |
| EBIT | -4.70M | -483.20K | -396.20K | -278.50K | 34.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.10 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.06 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.10 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | -0.06 | -0.01 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 45.87M | 45.63M | 45.30M | 45.60M | 45.60M |
| Average Diluted Shares Outstanding | 45.87M | 45.63M | 45.30M | 45.60M | 45.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
